Methyl sulfone induces Loss of metastatic properties and reemergence of normal phenotypes in a metastatic Cloudman S-91 (M3) murine melanoma Cell line

PLoS ONE

Volumn 5, Issue 8, 2010, Pages

  Caron, Joan McIntyre ^a   Bannon, Marissa ^a   Rosshirt, Lindsay ^a   Luis, Jessica ^a   Monteagudo, Luke ^a   Caron, John M ^a   Sternstein, Gerson Marc ^a  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIMETHYL SULFONE; ANTINEOPLASTIC AGENT; DIMETHYL SULFOXIDE; SULFONE;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CELL TRANSFORMATION; CONTACT INHIBITION; CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; EXTRACELLULAR MATRIX; MELANOCYTE; MELANOMA CELL; MELANOSOME; METASTASIS INHIBITION; MOUSE; NONHUMAN; SENESCENCE; WOUND HEALING; ANIMAL; CELL AGING; CELL MOTION; CYTOLOGY; DRUG EFFECT; EXPERIMENTAL MELANOMA; METABOLISM; METASTASIS; PATHOLOGY; PHENOTYPE; TIME; TUMOR CELL LINE;

MURINAE;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL AGING; CELL LINE, TUMOR; CELL MOVEMENT; DIMETHYL SULFOXIDE; EXTRACELLULAR MATRIX; MELANOCYTES; MELANOMA, EXPERIMENTAL; MICE; NEOPLASM METASTASIS; PHENOTYPE; SULFONES; TIME FACTORS; WOUND HEALING;

EID: 77957817024     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0011788     Document Type: Article

References (29)

1. Simon JA, Bedalov A (2004) Yeast as a model system for anticancer drugdiscovery. Nat Rev Cancer 4: 481-492.
2. Rose SE, Chalk JB, Galloway GJ, Doddrell DM (2000) Detection of dimethylsulfone in the human brain by in vivo proton magnetic resonance spectroscopy.Magn Reson Imaging 18: 95-98.
3. Steely JS (1994) Chemiluminescence detection of sulfur compounds in cookedmilk. In: Mussinan K, ed. Sulfur Compounds in Foods. Washington, DC:American Chemical Society. 8 p.
4. Barrager E, Veltmann JR, Jr., Schauss AG, Schiller RN (2002) A multicentered,open-label trial on the safety and efficacy of methylsulfonylmethane in thetreatment of seasonal allergic rhinitis. J Altern Complement Med 8: 167-173.
5. Horvath K, Noker PE, Somfai-Relle S, Glavits R, Financsek I, et al. (2002)Toxicity of methylsulfonylmethane in rats. Food Chem Toxicol 40: 1459-1462.
6. Donoso JA, Illanes JP, Samson F (1977) Dimethylsulfoxide action on fastaxoplasmic transport and ultrastructure of vagal axons. Brain Res 120: 287-301.
7. Walker L, Walker MC, Parris CN, Masters JR (1988) Intravesical chemotherapy:combination with dimethyl sulfoxide does not enhance cytotoxicity in vitro.Urol Res 16: 329-331.
8. Society AC (1983) Unproven methods of cancer management. Dimethylsulfoxide (DMSO). CA Cancer J Clin 33.
9. Haldar S, Chintapalli J, Croce CM (1996) Taxol induces bcl-2 phosphorylationand death of prostate cancer cells. Cancer Res 56: 1253-1255.
10. Hashimoto H, Tokunaka S, Sasaki M, Nishihara M, Yachiku S (1992)Dimethylsulfoxide enhances the absorption of chemotherapeutic drug instilledinto the bladder. Urol Res 20: 233-236.
11. Sahai E (2007) Illuminating the metastatic process. Nat Rev Cancer 7: 737-749.
12. Dimri GP, Lee X, Basile G, Acosta M, Scott G, et al. (1995) A biomarker thatidentifies senescent human cells in culture and in aging skin in vivo. Proc NatlAcad Sci U S A 92: 9363-9367.
13. Wang Y, Blandino G, Oren M, Givol D (1998) Induced p53 expression in lungcancer cell line promotes cell senescence and differentially modifies thecytotoxicity of anti-cancer drugs. Oncogene 17: 1923-1930.
14. Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, et al (2009)Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 27: 6199-6206.
15. Lovelock JE (1972) Atmospheric dimethyl sulfide and the natural sulfure cycle.Nature 237: 2.
16. Kruse PF, Jr., Miedema E (1965) Production and characterization of multiplelayeredpopulations of animal cells. J Cell Biol 27: 273-279.
17. Stoker MG, Rubin H (1967) Density dependent inhibition of cell growth inculture. Nature 215: 171-172.
18. Fagotto F, Gumbiner BM (1996) Cell contact-dependent signaling. Dev Biol180: 445-454.
19. Lanosa XA, Colombo JA (2008) Cell contact-inhibition signaling as part ofwound-healing processes in brain. Neuron Glia Biol 4: 27-3420.
20. Castaigne S, Chomienne C, Daniel MT, Ballerini P, Berger R, et al. (1990) Alltransretinoic acid as a differentiation therapy for acute promyelocytic leukemia.I. Clinical results. Blood 76: 1704-1709.
21. Advani SH, Nair R, Bapna A, Gladstone B, Kadam P, et al. (1999) Acutepromyelocytic leukemia: all-trans retinoic acid (ATRA) along with chemotherapyis superior to ATRA alone. Am J Hematol 60: 87-93.
22. Michaloglou C, Vredeveld LC, Soengas MS, Denoyelle C, Kuilman T, et al.(2005) BRAFE600-associated senescence-like cell cycle arrest of human naevi.Nature 436: 720-724.
23. Nishikawa SI, Osawa M (2005) Melanocyte system for studying stem cell niche.Ernst Schering Res Found Workshop. pp 1-13.
24. Ben-Porath I, Weinberg RA (2005) The signals and pathways activating cellularsenescence. Int J Biochem Cell Biol 37: 961-976.
25. Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW (1997) Oncogenic rasprovokes premature cell senescence associated with accumulation of p53 andp16INK4a. Cell 88: 593-602.
26. Roninson IB (2003) Tumor cell senescence in cancer treatment. Cancer Res 63:2705-2715.
27. Collado M, Gil J, Efeyan A, Guerra C, Schuhmacher AJ, et al. (2005) Tumourbiology: senescence in premalignant tumours. Nature 436: 642.
28. Collado M, Blasco MA, Serrano M (2007) Cellular senescence in cancer andaging. Cell 130: 223-233.
29. Lleonart ME, Artero-Castro A, Kondoh H (2009) Senescence induction; apossible cancer therapy. Mol Cancer 8: 3.